Medical Information Only: This medication is not sold on this site. The information provided is for reference purposes only. Please consult your local physician or pharmacist for treatment.

Planipart: Full Drug Profile

Medically reviewed by Min Clinic Staff | Updated: January 2026

Planipart - General Information

A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. [PubChem]

 

Pharmacology of Planipart

Planipart is a substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. Although approved for use in some countries, as of fall, 2006, clenbuterol is not an ingredient of any therapeutic drug approved by the U.S. Food and Drug Administration.

 

Additional information about Planipart

Planipart Indication: Used as a bronchodilator in the treatment of asthma patients. Mechanism Of Action: Not Available Drug Interactions: Not Available Food Interactions: Not Available Generic Name: Clenbuterol Synonyms: Clenbuterolum [inn-latin] Drug Category: Adrenergic beta-Agonists; Bronchodilator Agents; Sympathomimetics Drug Type: Small Molecule; Approved Other Brand Names containing Clenbuterol: Planipart; Absorption: 89-98% orally Toxicity (Overdose): Not Available Protein Binding: Not Available Biotransformation: Not Available Half Life: 36-39 hours Dosage Forms of Planipart: Not Available Chemical IUPAC Name: 1-(4-amino-3,5-dichlorophenyl)-2-(tert-butylamino)ethanol Chemical Formula: C12H18Cl2N2O Clenbuterol on Wikipedia: https://en.wikipedia.org/wiki/Clenbuterol Organisms Affected: Humans and other mammals